Loading provider…
Loading provider…
Neurology Physician in Miami, FL
NPI: 1134157035Primary Practice Location
JACKSON HEALTH SYSTEM
1611 Nw 12th Ave, Miami, FL
Primary Employer
UMiami Medicine - Neurology
umiamihealth.org
HQ Phone
Get MD Deborah's Phone Numberphone_androidMobile
Get MD Deborah's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1996 - 2026
MN State Medical License
1989 - 1996

American Board of Psychiatry and Neurology
Neurology
Carver College of Medicine
medicine.uiowa.edu
Medical School
Until 1978
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
Residency • Neurology
1983 - 1985
University of Iowa Hospitals and Clinics
Residency • Neurology
1979 - 1983
Internship • Internal Medicine
1978 - 1979
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 70 | 98 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 24 | 26 |
| 3 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 21 | 22 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 19 | 20 |
Authors: Francisco Vega, Jonathan Schatz, Daniel Cassidy
Publication Date: 2019-11-15
Authors: Vasu Saini, Jason Margolesky, Aditi Dhir, Joshua Lukas, James Hoffman, Ariana Rudnick
Journal: Clin Lymphoma Myeloma Leuk
Publication Date: 2020-02-19
Editorial: Glioblastoma in the elderly
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Placebo, OTHER: Questionnaire Administration, OTHER: Quality-of-Life Assessment, DRUG: Oxaliplatin, DRUG: Duloxetine, DRUG: Duloxetine Hydrochloride
Lead Sponsor: Tocagen Inc.
Intervention / Treatment: DRUG: Temozolomide, BIOLOGICAL: Bevacizumab, DRUG: Lomustine, DRUG: Toca FC, BIOLOGICAL: Toca 511
Lead Sponsor: Macarena De La Fuente, MD
Intervention / Treatment: PROCEDURE: Leukapheresis, DRUG: Imiquimod, BIOLOGICAL: Tumor Lysate, BIOLOGICAL: Dendritic Cell Vaccine